1. Home
  2. RIGL vs CLDT Comparison

RIGL vs CLDT Comparison

Compare RIGL & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RIGL
  • CLDT
  • Stock Information
  • Founded
  • RIGL 1996
  • CLDT 2009
  • Country
  • RIGL United States
  • CLDT United States
  • Employees
  • RIGL N/A
  • CLDT N/A
  • Industry
  • RIGL Biotechnology: Pharmaceutical Preparations
  • CLDT Real Estate Investment Trusts
  • Sector
  • RIGL Health Care
  • CLDT Real Estate
  • Exchange
  • RIGL Nasdaq
  • CLDT Nasdaq
  • Market Cap
  • RIGL 335.5M
  • CLDT 374.7M
  • IPO Year
  • RIGL 2000
  • CLDT 2010
  • Fundamental
  • Price
  • RIGL $38.85
  • CLDT $7.61
  • Analyst Decision
  • RIGL Buy
  • CLDT Strong Buy
  • Analyst Count
  • RIGL 5
  • CLDT 2
  • Target Price
  • RIGL $38.20
  • CLDT $10.75
  • AVG Volume (30 Days)
  • RIGL 995.6K
  • CLDT 264.3K
  • Earning Date
  • RIGL 08-05-2025
  • CLDT 08-06-2025
  • Dividend Yield
  • RIGL N/A
  • CLDT 4.72%
  • EPS Growth
  • RIGL N/A
  • CLDT N/A
  • EPS
  • RIGL 5.43
  • CLDT 0.03
  • Revenue
  • RIGL $267,921,000.00
  • CLDT $310,140,000.00
  • Revenue This Year
  • RIGL $59.93
  • CLDT N/A
  • Revenue Next Year
  • RIGL N/A
  • CLDT $0.45
  • P/E Ratio
  • RIGL $7.15
  • CLDT $277.86
  • Revenue Growth
  • RIGL 105.62
  • CLDT N/A
  • 52 Week Low
  • RIGL $12.66
  • CLDT $5.83
  • 52 Week High
  • RIGL $43.72
  • CLDT $10.00
  • Technical
  • Relative Strength Index (RSI)
  • RIGL 68.57
  • CLDT 63.27
  • Support Level
  • RIGL $39.00
  • CLDT $7.57
  • Resistance Level
  • RIGL $42.08
  • CLDT $7.82
  • Average True Range (ATR)
  • RIGL 2.32
  • CLDT 0.16
  • MACD
  • RIGL -0.37
  • CLDT 0.06
  • Stochastic Oscillator
  • RIGL 53.26
  • CLDT 76.92

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest

Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.

Share on Social Networks: